Expanding the Phenotypic Spectrum of GPI Anchoring Deficiency Due to Biallelic Variants in GPAA1
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received March 28, 2021
- Accepted in final form August 9, 2021
- First Published October 21, 2021.
Author Disclosures
- Alison M.R. Castle, MD (acastle{at}cheo.on.ca),
- Smrithi Salian, PhD (smriti.smz{at}gmail.com),
- Haim Bassan, MD (haim.bassan{at}gmail.com),
- Efrat Sofrin-Drucker, MD (efratsof{at}clalit.org.il),
- Raffaella Cusmai, MD (raffaella.cusmai{at}opbg.net),
- Kristin C. Herman, MD (kcherman{at}ucdavis.edu),
- Delphine Heron, MD (delphine.heron{at}aphp.fr),
- Boris Keren, MD, PhD (boris.keren{at}aphp.fr),
- Devon L. Johnstone, MD, MSc (devon.johnstone{at}uottawa.ca),
- Wendy Mears, PhD (wmears{at}cheo.on.ca),
- Susanne Morlot, MD (morlot.susanne{at}mh-hannover.de),
- Thi Tuyet Mai Nguyen, PhD (ducmai.nguyen{at}gmail.com),
- Rachel Rock, MD (rokrachel9{at}gmail.com),
- Elliot Stolerman, MD (estolerman{at}ggc.org),
- Julia Russo, MS (jrusso{at}ambrygen.com),
- William Boyce Burns, MD (william.burns{at}nationwidechildrens.org),
- Julie R. Jones, PhD (juliejones{at}ggc.org),
- Valentina Serpieri, PhD (valentina.serpieri01{at}universitadipavia.it),
- Hannah Wallaschek, MD (wallaschek.hannah{at}mh-hannover.de),
- Ginevra Zanni, MD, PhD (ginevra.zanni{at}opbg.net),
- David A. Dyment, DPhil, MD (ddyment{at}cheo.on.ca) and
- Philippe M. Campeau, MD
- Alison M.R. Castle, MD (acastle{at}cheo.on.ca),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Smrithi Salian, PhD (smriti.smz{at}gmail.com),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Haim Bassan, MD (haim.bassan{at}gmail.com),
NONE
NONE
NONE
NONE
NONE
NONE
My wife is employed during the last two years in a pharma company Name of company- BiomX Area: unrelated to this paper: Biomx is developing phage cocktails designed to target and destroy bacteria. Position- chief development officer
NONE
NONE
NONE
NONE
NONE
NONE
(1) Tel Aviv University grant, Israel (unrelated to this paper)
(1) the Shalem Fund, Israel (unrelated to this paper) [the Shalem fund supports Israeli research in the field of developmental and intellectual disabilities]
NONE
NONE
NONE
(1) Biomx, 2019 (stock/options for my wife) unrelated to this paper
NONE
NONE
- Efrat Sofrin-Drucker, MD (efratsof{at}clalit.org.il),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Raffaella Cusmai, MD (raffaella.cusmai{at}opbg.net),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Kristin C. Herman, MD (kcherman{at}ucdavis.edu),
vascular EDS advisory Board Acer Theraputics (commercial)- board no longer active
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Expert medical witness for some cases
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Expert medical witness for case involving Trader Joe's
- Delphine Heron, MD (delphine.heron{at}aphp.fr),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Boris Keren, MD, PhD (boris.keren{at}aphp.fr),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Devon L. Johnstone, MD, MSc (devon.johnstone{at}uottawa.ca),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Wendy Mears, PhD (wmears{at}cheo.on.ca),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Susanne Morlot, MD (morlot.susanne{at}mh-hannover.de),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Thi Tuyet Mai Nguyen, PhD (ducmai.nguyen{at}gmail.com),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Rachel Rock, MD (rokrachel9{at}gmail.com),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Elliot Stolerman, MD (estolerman{at}ggc.org),
NONE
NONE
NONE
Biochemie - ad hoc reviewer for genetics 2021
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Julia Russo, MS (jrusso{at}ambrygen.com),
NONE
NONE
NONE
NONE
NONE
NONE
Ambry Genetics, Genetic Counselor I, Reporting, 4 months
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- William Boyce Burns, MD (william.burns{at}nationwidechildrens.org),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Julie R. Jones, PhD (juliejones{at}ggc.org),
NONE
NONE
NONE
NONE
NONE
NONE
Greenwood Genetic Center, Director of the Clinical Genomics Sequencing Program, 2014-present
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Valentina Serpieri, PhD (valentina.serpieri01{at}universitadipavia.it),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Hannah Wallaschek, MD (wallaschek.hannah{at}mh-hannover.de),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ginevra Zanni, MD, PhD (ginevra.zanni{at}opbg.net),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- David A. Dyment, DPhil, MD (ddyment{at}cheo.on.ca) and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Philippe M. Campeau, MD
Consulting fees from Sanofi and Alexion
NONE
NONE
Member of the editorial board for: European journal of human genetics
NONE
NONE
NONE
Consulting fees from Alexion Pharmaceuticals
NONE
NONE
NONE
NONE
Canadian institutes of health research grant CIHR RN324373 (Characterization of a new group of vesicular transport diseases, 2014-2019, PI), RN315908 Fonds de recherche du Québec  Santé award FRQS 30647 for clinician-scientists
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Genetics (A.M.R.C., D.A.D.), Children's Hospital of Eastern Ontario, Ottawa; CHU Sainte Justine Research Centre (S.S., T.T.M.N., P.M.C.), Université de Montréal, Quebec, Canada; Pediatric Neurology & Development Center (H.B.), Shamir (Assaf Harofeh) Medical Center, Zerifin, Tel Aviv University; Pediatric Genetics Clinic (E.S.-D.), Schneider Children's Medical Centre, Petach Tikya, Tel Aviv University, Israel; Unit of Neurophysiology, Department of Neurosciences, IRCCS, Bambino Gesù Research Hospital, Rome, Italy; Section of Medical Genomics (K.C.H.), Medical Investigation of Neurodevelopmental Disorders Institute, University of California, Davis, Sacramento; APHP (B.K.), Département de Génétique, Groupe Hospitalier Pitié Salpêtrière, Paris, France; APHP Sorbonne-Université (D.H.), UF Génétique Médicale, Hôpitaux Pitié-Salpêtrière et Trousseau, Centre de Référence “déficiences intellectuelles de causes rares”, Paris, France; Children's Hospital of Eastern Ontario Research Institute (D.L.J., W. M., D.A.D.), Ottawa, Canada; Department of Human Genetics (S.M., H.W.), Hannover Medical School, Germany; Biochemical Diseases (R.R.), BC Children's Hospital, Vancouver, British Columbia, Canada; Greenwood Genetic Center (E.S., J.R., W.B.B., J.R.J.), SC; Department of Molecular Medicine (V.S.), University of Pavia; Neurogenetics Research Center (V.S.), IRCCS Mondino Foundation, Pavia; Unit of Neuromuscular and Neurodegenerative Disorders (G.Z.), Department of Neurosciences, IRCCS, Bambino Gesù Research Hospital, Rome, Italy; and Medical Genetics Division (P.M.C.), Department of Pediatrics, Sainte-Justine University Hospital Centre, Montreal, Quebec, Canada.
- Correspondence
Dr. Campeau p.campeau{at}umontreal.ca
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Jeffrey Allen and Dr. Nicholas Purcell
► Watch
Related Articles
- No related articles found.